VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot C5367AA: VAERS reports

50 VAERS reports list lot C5367AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2019-03-15 and 2021-01-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
50
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2456%
General / Systemic (non-local)512%
Gastrointestinal49%
Neurological37%
Allergic / Anaphylactic25%
Respiratory25%
Autoimmune / Immune-mediated12%
Dermatological (non-injection-site)12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York5
Massachusetts4
Maryland4
Virginia4
Texas4
Ohio4
Illinois3
Pennsylvania2
Louisiana2
Michigan2
New Jersey2
Wyoming2

Reports by month received

2019-031
2019-052
2019-081
2019-105
2020-0225
2020-037
2020-042
2020-051
2020-062
2020-072
2020-091
2021-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.